XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.2

OPTIONS AND AWARDS (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions for Stock Options Granted

The Company used the following assumptions for stock options granted during the three months ended June 30, 2024 and 2023:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility												Weighted Average Dividend Yield
2024						173						4.4%						6.1 years						40.6%												0.2%
2023						191						3.7%						6.3 years						41.4%												0.3%

The Company used the following assumptions for stock options granted during the six months ended June 30, 2024 and 2023:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility						Weighted Average Dividend Yield
2024						354						4.4%						6.1 years						40.8%						0.2%
2023						413						3.9%						6.3 years						41.5%						0.3%

Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants

For the six months ended June 30, 2024 and 2023, the following represents the exercise price and fair value displayed at grant date for stock option grants:

Grant Year						Granted						Weighted Average Exercise Price						Weighted Average Fair Value of Options
2024						354						$	120.98					$	55.39
2023						413						$	90.31					$	41.46

Schedule of Employee Stock Option Roll Forward

The following table represents the employee stock option activity during the six months ended June 30, 2024:

			Number of Options Outstanding						Weighted Average Exercise Price						Number of Options Vested						Weighted Average Exercise Price of Options Vested
January 1, 2024			3,991						$	62.65					1,887						$	39.58
Granted			354						120.98
Forfeited			(42)						82.22
Exercised			(336)						30.75
June 30, 2024			3,967						$	70.34					1,881						$	46.34

Schedule of Aggregate Intrinsic Value of Options

The aggregate intrinsic value of options outstanding, vested, expected to vest and exercised as of June 30, 2024 and December 31, 2023 is as follows:

Options						June 30, 2024						December 31, 2023
Outstanding						$	211,650					$	197,819
Vested						145,531						137,048
Expected to vest						61,779						56,759

Schedule of Nonvested Restricted Stock Awards

A summary of the status of the Company's non-vested restricted stock awards as of June 30, 2024 and changes during the six months ended June 30, 2024 is presented below:

			Non-Vested Restricted Awards						Weighted Average Grant Date Fair Value
Nonvested at January 1, 2024			431						$	78.91
Granted			137						119.44
Vested			(147)						88.54
Forfeited			(11)						80.17
Nonvested at June 30, 2024			410						$	88.91

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the three and six months ended June 30, 2024 and 2023 was as follows:

			Three Months Ended June 30,												Six Months Ended June 30,
			2024						2023						2024						2023
Stock-based compensation expense related to stock options			$	5,518					$	4,963					$	10,506					$	8,388
Stock-based compensation expense related to restricted stock awards			2,936						3,481						5,663						6,209
Stock-based compensation expense related to restricted stock awards to non-employee directors			524						437						1,040						857
TOTAL			$	8,978					$	8,881					$	17,209					$	15,454

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration